When PHLPP2, a PH domain leucine‐rich repeat protein phosphatase 2, was knocked down, an increase in phosphorylation of AKT was observed, suggesting that m6A modification of pri‐miR‐25 ultimately contributes to the activation of the AKT pathway and pancreatic cancer progression [20]. The gene discussed is AKT1; the disease is pancreatic neoplasm.